JP6640826B2 - 微粒子化ワルトン膠質 - Google Patents

微粒子化ワルトン膠質 Download PDF

Info

Publication number
JP6640826B2
JP6640826B2 JP2017500060A JP2017500060A JP6640826B2 JP 6640826 B2 JP6640826 B2 JP 6640826B2 JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017500060 A JP2017500060 A JP 2017500060A JP 6640826 B2 JP6640826 B2 JP 6640826B2
Authority
JP
Japan
Prior art keywords
micronized
walton
composition
particles
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017500060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017525671A5 (https=
JP2017525671A (ja
Inventor
スペンサー，ランドール
シス，ソマリー
クーブ，トーマス
Original Assignee
ミメディクス グループ インコーポレイテッド
ミメディクス グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミメディクス グループ インコーポレイテッド, ミメディクス グループ インコーポレイテッド filed Critical ミメディクス グループ インコーポレイテッド
Publication of JP2017525671A publication Critical patent/JP2017525671A/ja
Publication of JP2017525671A5 publication Critical patent/JP2017525671A5/ja
Application granted granted Critical
Publication of JP6640826B2 publication Critical patent/JP6640826B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/065—Thymocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2017500060A 2014-07-08 2015-07-07 微粒子化ワルトン膠質 Active JP6640826B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022084P 2014-07-08 2014-07-08
US62/022,084 2014-07-08
PCT/US2015/039444 WO2016007554A1 (en) 2014-07-08 2015-07-07 Micronized wharton's jelly

Publications (3)

Publication Number Publication Date
JP2017525671A JP2017525671A (ja) 2017-09-07
JP2017525671A5 JP2017525671A5 (https=) 2018-08-16
JP6640826B2 true JP6640826B2 (ja) 2020-02-05

Family

ID=55064792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500060A Active JP6640826B2 (ja) 2014-07-08 2015-07-07 微粒子化ワルトン膠質

Country Status (5)

Country Link
US (3) US20160008410A1 (https=)
EP (1) EP3167049A4 (https=)
JP (1) JP6640826B2 (https=)
AU (1) AU2015287920A1 (https=)
WO (1) WO2016007554A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8182840B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
WO2016111899A1 (en) 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック，インク． 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
CN109219442A (zh) 2016-04-04 2019-01-15 Omeza有限公司 鱼油局部组合物
US10478531B2 (en) * 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
AU2020260133A1 (en) * 2019-04-16 2021-11-18 Lifenet Health Birth tissue-derived products and preparation and uses thereof
WO2022186946A1 (en) * 2021-03-03 2022-09-09 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
US20220280573A1 (en) * 2021-03-03 2022-09-08 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
EP4487878A1 (en) * 2022-03-01 2025-01-08 National Yang Ming Chiao Tung University Wharton's jelly product capable of promoting osteogenesis

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CA2060223C (en) * 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5558071A (en) 1994-03-07 1996-09-24 Combustion Electromagnetics, Inc. Ignition system power converter and controller
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
MXPA02009031A (es) 2000-03-14 2004-08-19 Amylin Pharmaceuticals Inc Efectos del peptido-1(7-36) tipo glucagon en la motilidad antro-piloro.duodenal.
JP4451658B2 (ja) * 2001-10-18 2010-04-14 ライフセル コーポレーション 組織および器官のリモデリング
US8067044B2 (en) 2004-02-13 2011-11-29 Cognis France S.A.S. Cosmetic compositions containing an extract of leaves of the Castanea sativa plant and cosmetic treatments
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
BRPI0717171B1 (pt) 2006-09-25 2023-10-17 Archer Daniels Midland Company Material superabsorvente
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
EP4559488A3 (en) 2007-09-07 2025-08-13 MiMedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
EP2326306A1 (en) 2008-09-25 2011-06-01 Cephalon, Inc. Liquid formulations of bendamustine
CA2739166C (en) * 2008-10-10 2013-12-31 Julio Font Perez New biomaterial from wharton's jelly of the human umbilical cord
CA2771908C (en) 2009-08-25 2019-05-21 Tissuetech, Inc. Umbilical cord amniotic membrane products
CN102198292B (zh) 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
AU2012217975B2 (en) 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
KR102903446B1 (ko) 2011-02-14 2025-12-24 미메딕스 그룹 인크. 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
WO2012112441A1 (en) * 2011-02-14 2012-08-23 Mimedx Group Inc. Laminated tissue grafts composed of wharton's jelly and methods of making and using the same
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
CN103703069B (zh) * 2011-07-27 2017-05-03 普立万公司 可交联的生物增塑剂
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
HUE056817T2 (hu) 2011-12-30 2022-03-28 Amit Patel Eljárások és készítmények allogén sejt klinikai származtatására és terápiás alkalmazások
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US10857266B2 (en) 2012-08-15 2020-12-08 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
US10449220B2 (en) * 2013-08-30 2019-10-22 Mimedx Group, Inc. Micronized placental compositions comprising a chelator
EP3146039A4 (en) * 2014-05-21 2017-11-29 MiMedx Group, Inc. Micronized wharton's jelly
US20160000968A1 (en) 2014-07-07 2016-01-07 Mimedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same

Also Published As

Publication number Publication date
EP3167049A1 (en) 2017-05-17
US20190307812A1 (en) 2019-10-10
US10307443B2 (en) 2019-06-04
US20160346332A1 (en) 2016-12-01
WO2016007554A1 (en) 2016-01-14
AU2015287920A8 (en) 2017-02-02
US20160008410A1 (en) 2016-01-14
JP2017525671A (ja) 2017-09-07
EP3167049A4 (en) 2017-11-29
AU2015287920A1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
JP7304316B2 (ja) 微粉化ホウォートンゼリー
JP6640826B2 (ja) 微粒子化ワルトン膠質
JP7749620B2 (ja) コラーゲンおよび微粉化胎盤組織からなる組成物ならびにその調製および使用方法
JP6081378B2 (ja) 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
AU2015315228B2 (en) Micronized placental tissue compositions with optional sealant and methods of making and using the same
US12076348B2 (en) Micronized placental compositions comprising a chelator
AU2019272042A1 (en) Micronized placental tissue compositions and methods of making and using the same
JP2016529070A (ja) 成形胎盤組成物の美容的使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180704

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190806

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191010

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191210

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191226

R150 Certificate of patent or registration of utility model

Ref document number: 6640826

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250